Linda S Cox, MD | |
2222 E 2nd St, Casper, WY 82609-2060 | |
(307) 577-5222 | |
(075) 775-2253 |
Full Name | Linda S Cox |
---|---|
Gender | Female |
Speciality | Allergy & Immunology |
Location | 2222 E 2nd St, Casper, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750311213 | NPI | - | NPPES |
10707064 | Other | WY | CAQH |
11972A | Other | WY | STATE LICENSE |
CS02235 | Other | WY | CONTROLLED SUBSTANCE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 48973 (Florida) | Secondary |
207K00000X | Allergy & Immunology | 11972A (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Linda S Cox, MD 2222 E 2nd St, Casper, WY 82609-2060 Ph: (307) 577-5222 | Linda S Cox, MD 2222 E 2nd St, Casper, WY 82609-2060 Ph: (307) 577-5222 |
News Archive
A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth further investigation.
More than £6M of funding has been awarded to enhance the development of biopharmaceuticals. In total £6.5M will fund 12 projects to deliver commercially important results, such as industrial-scale production of antibodies, stem cell preservation at room temperature, biopharmaceutical production using microbes and commercial scale stem cell therapy.
In a continuing increase in breast cancer, one in nine women in the UK now risk contracting the disease during their lifetime.
Pre-registered and certified providers in the southwest, southeast, and north-central regions of the state have begun to receive the first doses of the live attenuated pandemic H1N1 influenza vaccine, also known by the brand name FluMist, the Pennsylvania Department of Health said today.
A team of neuroscientists has discovered important new information in the search for an effective treatment for Alzheimer's disease, the debilitating neurological disorder that afflicts more than 5.3 million Americans and is the sixth-leading cause of death in the United States. Hey-Kyoung Lee, associate professor in the University of Maryland Department of Biology, and her research team have shown that they may be able to eliminate debilitating side effects caused by a promising Alzheimer's drug by stimulating the brain's nicotine receptors.
› Verified 7 days ago
Kamlesh S Shah, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2222 East Second Street, Casper, WY 82609 Phone: 307-577-5222 Fax: 307-577-5225 |